Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 220

1.

Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.

Palmer JD, Siglin J, Yamoah K, Dan T, Champ CE, Bar-Ad V, Werner-Wasik M, Evans JJ, Kim L, Glass J, Farrell C, Andrews DW, Shi W.

J Neurooncol. 2015 May 30. [Epub ahead of print]

PMID:
26024653
2.

Tumor volume threshold for achieving improved conformity in VMAT and Gamma Knife stereotactic radiosurgery for vestibular schwannoma.

Kim H, Potrebko P, Rivera A, Liu H, Eldredge-Hindy HB, Gunn V, Werner-Wasik M, Andrews DW, Evans JJ, Farrell CJ, Judy K, Shi W.

Radiother Oncol. 2015 May;115(2):229-34. doi: 10.1016/j.radonc.2015.03.031. Epub 2015 May 18.

PMID:
25998805
3.

Tunable hydrogel thin films from reactive synthetic polymers as potential two-dimensional cell scaffolds.

Goujon LJ, Hariharan S, Sayyar B, Burke NA, Cranston ED, Andrews DW, Stöver HD.

Langmuir. 2015 May 26;31(20):5623-32. doi: 10.1021/acs.langmuir.5b00376. Epub 2015 May 12.

PMID:
25907892
4.

Molecular Pathways: Leveraging the BCL-2 Interactome to Kill Cancer Cells-Mitochondrial Outer Membrane Permeabilization and Beyond.

Brahmbhatt H, Oppermann S, Osterlund EJ, Leber B, Andrews DW.

Clin Cancer Res. 2015 Jun 15;21(12):2671-6. doi: 10.1158/1078-0432.CCR-14-0959. Epub 2015 Apr 2.

PMID:
25838396
5.

5-aminolevulinic acid induced protoporphyrin IX as a fluorescence marker for quantitative image analysis of high-grade dysplasia in Barrett's esophagus cellular models.

Yeh SC, Sahli S, Andrews DW, Patterson MS, Armstrong D, Provias J, Fang Q.

J Biomed Opt. 2015 Mar 1;20(3):36010. doi: 10.1117/1.JBO.20.3.036010. No abstract available.

PMID:
25790343
6.

Distinct lipid effects on tBid and Bim activation of membrane permeabilization by pro-apoptotic Bax.

Shamas-Din A, Bindner S, Chi X, Leber B, Andrews DW, Fradin C.

Biochem J. 2015 May 1;467(3):495-505. doi: 10.1042/BJ20141291.

PMID:
25714678
7.

5-aminolevulinic acid for quantitative seek-and-treat of high-grade dysplasia in Barrett's esophagus cellular models.

Yeh SC, Ling CS, Andrews DW, Patterson MS, Diamond KR, Hayward JE, Armstrong D, Fang Q.

J Biomed Opt. 2015 Feb 1;20(2):28002. doi: 10.1117/1.JBO.20.2.028002.

PMID:
25671673
8.

The use of FLIM-FRET for the detection of mitochondria-associated protein interactions.

Osterlund EJ, Liu Q, Andrews DW.

Methods Mol Biol. 2015;1264:395-419. doi: 10.1007/978-1-4939-2257-4_34.

PMID:
25631031
9.

Enhancement of glioma-specific immunity in mice by "NOBEL", an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide.

Morin-Brureau M, Hooper KM, Prosniak M, Sauma S, Harshyne LA, Andrews DW, Hooper DC.

Cancer Immunol Immunother. 2015 Apr;64(4):447-57. doi: 10.1007/s00262-015-1654-z. Epub 2015 Jan 13.

PMID:
25579379
10.

The relative biological effectiveness of low-dose mammography quality X rays in the human breast MCF-10A cell line.

Mills CE, Thome C, Koff D, Andrews DW, Boreham DR.

Radiat Res. 2015 Jan;183(1):42-51. doi: 10.1667/RR13821.1. Epub 2014 Dec 23.

PMID:
25536231
11.

Pores of no return.

Andrews DW.

Mol Cell. 2014 Nov 20;56(4):465-6. doi: 10.1016/j.molcel.2014.11.005. Epub 2014 Nov 20.

PMID:
25459877
12.

Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm.

Harshyne LA, Hooper KM, Andrews EG, Nasca BJ, Kenyon LC, Andrews DW, Hooper DC.

Cancer Immunol Immunother. 2015 Mar;64(3):299-309. doi: 10.1007/s00262-014-1622-z. Epub 2014 Nov 14.

PMID:
25391690
13.

New insights into the targeting of a subset of tail-anchored proteins to the outer mitochondrial membrane.

Marty NJ, Teresinski HJ, Hwang YT, Clendening EA, Gidda SK, Sliwinska E, Zhang D, Miernyk JA, Brito GC, Andrews DW, Dyer JM, Mullen RT.

Front Plant Sci. 2014 Sep 4;5:426. doi: 10.3389/fpls.2014.00426. eCollection 2014.

14.

A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.

Wuthrick EJ, Curran WJ Jr, Camphausen K, Lin A, Glass J, Evans J, Andrews DW, Axelrod R, Shi W, Werner-Wasik M, Haacke EM, Hillman GG, Dicker AP.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):369-75. doi: 10.1016/j.ijrobp.2014.05.034. Epub 2014 Aug 4.

PMID:
25104067
15.

Regulating cell death at, on, and in membranes.

Chi X, Kale J, Leber B, Andrews DW.

Biochim Biophys Acta. 2014 Sep;1843(9):2100-13. doi: 10.1016/j.bbamcr.2014.06.002. Epub 2014 Jun 11. Review.

PMID:
24927885
16.

Multiple partners can kiss-and-run: Bax transfers between multiple membranes and permeabilizes those primed by tBid.

Shamas-Din A, Satsoura D, Khan O, Zhu W, Leber B, Fradin C, Andrews DW.

Cell Death Dis. 2014 Jun 5;5:e1277. doi: 10.1038/cddis.2014.234.

PMID:
24901048
17.

The proapoptotic protein tBid forms both superficially bound and membrane-inserted oligomers.

Shivakumar S, Kurylowicz M, Hirmiz N, Manan Y, Friaa O, Shamas-Din A, Masoudian P, Leber B, Andrews DW, Fradin C.

Biophys J. 2014 May 20;106(10):2085-95. doi: 10.1016/j.bpj.2014.03.049.

18.

Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial.

Shi W, Lawrence YR, Choy H, Werner-Wasik M, Andrews DW, Evans JJ, Judy KD, Farrell CJ, Moshel Y, Berger AC, Bar-Ad V, Dicker AP.

J Neurooncol. 2014 Jun;118(2):313-9. doi: 10.1007/s11060-014-1433-2. Epub 2014 Apr 13.

PMID:
24728831
19.

After embedding in membranes antiapoptotic Bcl-XL protein binds both Bcl-2 homology region 3 and helix 1 of proapoptotic Bax protein to inhibit apoptotic mitochondrial permeabilization.

Ding J, Mooers BH, Zhang Z, Kale J, Falcone D, McNichol J, Huang B, Zhang XC, Xing C, Andrews DW, Lin J.

J Biol Chem. 2014 Apr 25;289(17):11873-96. doi: 10.1074/jbc.M114.552562. Epub 2014 Mar 10.

20.

Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme.

Champ CE, Palmer JD, Volek JS, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Shi W.

J Neurooncol. 2014 Mar;117(1):125-31. doi: 10.1007/s11060-014-1362-0. Epub 2014 Jan 19.

PMID:
24442482
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk